Leonard H Sigal MD FACP

20+ years in academia (basic and clinical research, education)
20+ years in pharma in development at BMS and NovoNordisk, then member of the Global Therapeutic Area Leadership at PAREXEL, most recently as an independent consultant to small and medium biopharma and pharma, especially working with early development on CDPs and protocol development, from scientific background to choice of disease targets and clinical/laboratory endpoints
Elected Master, American College of Rheumatology.
Skilled at expressing complicated and/or difficult concepts in understandable English; wrote 59 papers for the JCR: Journal of Clinical Rheumatology in a series entitled “Basic Science for the Clinician”